
View larger version (37K):
[in a new window]
|
Fig. 1. Bpag1 isoforms expressed in C2C12 myoblasts, and the N-terminal fusion proteins used in this study. (A) The Bpag1e and Bpag1b isoforms. Bpag1b includes the N-terminal unique region encoded by exons A or A' (Brown et al., 1995 ), an ABD consisting of two calponin homology domains (CH1 and CH2), a plakin domain, an intermediate filament binding domain (IFBD2), a spectrin-repeat region (SR rod), an EF-hand, and a GAS2 homology region which includes part of an MTBD. Only the plakin domain is shared by the Bpag1e isoform, which has a C-terminal half consisting of a coiled-coil rod domain (C-C rod) and an alternate intermediate filament binding domain (IFBD1). The Bpag1a isoform (not shown) differs from the Bpag1b isoform only in that it lacks the IFBD2 and surrounding region. The peptide sequence used for isoform-specific antibody production is also shown. (B) Semiquantitative RT-PCR using primers against various regions of Bpag1. The results indicate that Bpag1b is the predominant isoform expressed in C2C12 myoblasts, although a band amplified from the IFBD1 region of Bpag1e was also detected at low levels. Conversely, regions from the Bpag1b mRNA were detected at low levels in mouse skin, whereas the IFBD1 region from the Bpag1e mRNA was prominent in skin. Actin mRNA amplification served as a control for RNA amount used. (C) The various fusion proteins used in this study. FLAG and GFP western blots indicated that each fusion protein was expressed at the appropriate size. B, BglII; R, EcoRI; S, SalI; Sa, SapI.
|